MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on November 28, 2006; DOI: 10.1124/mol.106.030445


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.030445v1
71/3/769    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tapia, L.
Right arrow Articles by Lindstrom, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tapia, L.
Right arrow Articles by Lindstrom, J. M.


Received for publication September 7, 2006.
Revised November 21, 2006.
Accepted for publication November 28, 2006.

Ca++ Permeability of the ({alpha}4)3({beta}2)2 Stoichiometry Greatly Exceeds That of ({alpha}4)2({beta}2)3 Human AChRs

Laura Tapia 1, Alexander Kuryatov 2, Jon M. Lindstrom 3*

1 Universidad Autonoma de Madrid 2 University of Pennsylvania 3 University of Pennsylvania Medical School

* Address correspondence to: E-mail: jslkk{at}mail.med.upenn.edu

Abstract

Human {alpha}4{beta}2 nicotinic acetylcholine receptors (AChRs) expressed in Xenopus oocytes or transfected cell lines are present as a mixture of two stoichiometries, ({alpha}4)2({beta}2)3 and ({alpha}4)3({beta}2)2, which differ depending on whether a {beta}2 or {alpha}4 subunit occupies the accessory subunit position corresponding to {beta}1 subunits of muscle AChRs. Pure populations of each stoichiometry can be expressed in oocytes by combining a linked pair of {alpha}4 and {beta}2 with free {beta}2 to produce the ({alpha}4)2({beta}2)3 stoichiometry or with free {alpha}4 to produce the ({alpha}4)3({beta}2)2 stoichiometry. We show that the ({alpha}4)3({beta}2)2 stoichiometry and the ({alpha}4)2({beta}2)2{beta}3 and ({alpha}4)2({beta}2)2{alpha}5 subtypes in which {beta}3 or {alpha}5 occupy the accessory positions have much higher permeability to Ca++ than does ({alpha}4)2({beta}2)3 and suggest that this could be physiologically significant in triggering signaling cascades if this stoichiometry or these subtypes were found in vivo. We show that Ca++ permeability is determined by charged amino acids at the extracellular end of the M2 transmembrane domain which could form a ring of amino acids at the outer end of the cation channel. {alpha}4, {alpha}5, and {beta}3 subunits all have a homologous glutamate in M2 which contributes to high Ca++ permeability, whereas {beta}2 has a lysine at this position. Subunit combinations or single amino acids changes at this ring which have all negative charges or a mixture of positive and negative charged amino acids are permeable to Ca++. All positive charges in the ring prevent Ca++ permeability. Increasing the proportion of negative charges is associated with increasing permeability to Ca++.


Key words: Nicotinic cholinergic, Func. analysis receptor/ion channel mutants


This article has been cited by other articles:


Home page
J. Neurosci.Home page
S. M. Kassam, P. M. Herman, N. M. Goodfellow, N. C. Alves, and E. K. Lambe
Developmental Excitation of Corticothalamic Neurons by Nicotinic Acetylcholine Receptors
J. Neurosci., August 27, 2008; 28(35): 8756 - 8764.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. R. Livesey, M. A. Cooper, T. Z. Deeb, J. E. Carland, J. Kozuska, Tim. G. Hales, J. J. Lambert, and J. A. Peters
Structural Determinants of Ca2+ Permeability and Conduction in the Human 5-Hydroxytryptamine Type 3A Receptor
J. Biol. Chem., July 11, 2008; 283(28): 19301 - 19313.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Moroni, R. Vijayan, A. Carbone, R. Zwart, P. C. Biggin, and I. Bermudez
Non-Agonist-Binding Subunit Interfaces Confer Distinct Functional Signatures to the Alternate Stoichiometries of the {alpha}4{beta}2 Nicotinic Receptor: An {alpha}4-{alpha}4 Interface Is Required for Zn2+ Potentiation
J. Neurosci., July 2, 2008; 28(27): 6884 - 6894.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Kuryatov, J. Onksen, and J. Lindstrom
Roles of Accessory Subunits in {alpha}4{beta}2* Nicotinic Receptors
Mol. Pharmacol., July 1, 2008; 74(1): 132 - 143.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
J. LINDSTROM, J. LUO, and A. KURYATOV
Myasthenia Gravis and the Tops and Bottoms of AChRs: Antigenic Structure of the MIR and Specific Immunosuppression of EAMG Using AChR Cytoplasmic Domains
Ann. N.Y. Acad. Sci., June 1, 2008; 1132(1): 29 - 41.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Gotti, M. Moretti, N. M. Meinerz, F. Clementi, A. Gaimarri, A. C. Collins, and M. J. Marks
Partial Deletion of the Nicotinic Cholinergic Receptor {alpha}4 or {beta}2 Subunit Genes Changes the Acetylcholine Sensitivity of Receptor-Mediated 86Rb+ Efflux in Cortex and Thalamus and Alters Relative Expression of {alpha}4 and {beta}2 Subunits
Mol. Pharmacol., June 1, 2008; 73(6): 1796 - 1807.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Zwart, A. L. Carbone, M. Moroni, I. Bermudez, A. J. Mogg, E. A. Folly, L. M. Broad, A. C. Williams, D. Zhang, C. Ding, et al.
Sazetidine-A Is a Potent and Selective Agonist at Native and Recombinant {alpha}4{beta}2 Nicotinic Acetylcholine Receptors
Mol. Pharmacol., June 1, 2008; 73(6): 1838 - 1843.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. M. Drenan, R. Nashmi, P. Imoukhuede, H. Just, S. McKinney, and H. A. Lester
Subcellular Trafficking, Pentameric Assembly, and Subunit Stoichiometry of Neuronal Nicotinic Acetylcholine Receptors Containing Fluorescently Labeled {alpha}6 and 3 Subunits
Mol. Pharmacol., January 1, 2008; 73(1): 27 - 41.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics